Drdgold (DRDGF) Liabilities and Shareholders Equity (2017 - 2025)

Drdgold's Liabilities and Shareholders Equity history spans 9 years, with the latest figure at $670.6 million for Q2 2025.

  • For Q2 2025, Liabilities and Shareholders Equity rose 31.66% year-over-year to $670.6 million; the TTM value through Jun 2025 reached $2.1 billion, up 11.96%, while the annual FY2025 figure was $676.7 million, 33.78% up from the prior year.
  • Liabilities and Shareholders Equity for Q2 2025 was $670.6 million at Drdgold, up from $509.3 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $670.6 million in Q2 2025 and bottomed at $438.4 million in Q2 2023.
  • The 5-year median for Liabilities and Shareholders Equity is $456.7 million (2022), against an average of $504.8 million.
  • The largest annual shift saw Liabilities and Shareholders Equity surged 41.64% in 2021 before it decreased 4.02% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $448.9 million in 2021, then increased by 1.74% to $456.7 million in 2022, then decreased by 4.02% to $438.4 million in 2023, then increased by 16.18% to $509.3 million in 2024, then surged by 31.66% to $670.6 million in 2025.
  • Per Business Quant, the three most recent readings for DRDGF's Liabilities and Shareholders Equity are $670.6 million (Q2 2025), $509.3 million (Q2 2024), and $438.4 million (Q2 2023).